Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by GoTogetheron Aug 19, 2017 4:43pm
166 Views
Post# 26599934

Money Timelines > Refunding

Money Timelines > Refunding... LaserStock29, thanks for your contribution to this board.

Refunding, I guess it's more or less in the back of everybody's mind.
I know, It's somehow a slippery subject to discuss, but necessary to manage realistic expectations.
In the past you gave us frequently timelines regarding Theralase's cash position.

I'm struggling with two plots :

A - Burn Rate : 300/350 K per month > Kereport, April 6, 2017 
( At 10.03 minutes: Cash in the till 1.6/1.7 million. Burn rate 300/350 K. )

B - Burn Rate : 457 K per month > Sedar.com
Cash, end of 2016 : $ 2,970,198.
Cash, end of Q1 :    $ 1,598,322.  
                                $ 1,371,876 / 3 = 457 K
 
There's too much difference between A and B to feel comfortable.
Plot A would suggest a delay in refunding is possible, taking into account warrants that have been exercised.
Plot B would suggest refunding is imminent.

The Q2-results will be released end of this month, which will give us some more insights in the burn rate u,
but
... LaserStock29, I would like to know your thoughts on this subject.
Many thanks.


Bullboard Posts